Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149507482> ?p ?o ?g. }
- W2149507482 endingPage "711" @default.
- W2149507482 startingPage "707" @default.
- W2149507482 abstract "127 patients with suspected herpes simplex encephalitis (HSE) were entered in a prospective randomised study of acyclovir 10 mg/kg 8-hourly versus vidarabine 15 mg/kg daily for 10 days. The patients were consecutive and nearly all Swedish cases of HSE were included; they were treated in six university infectious diseases departments. The diagnosis of HSE was verified by brain biopsy and/or antibody responses in serum and cerebrospinal fluid. Of 53 confirmed cases of HSE (corresponding to 2 X 3 cases per million inhabitants per year in Sweden), 51 (27 acyclovir, 24 vidarabine) were evaluable for analysis of efficacy. The mortality was 19% in the acyclovir-treated group versus 50% in the vidarabine group (p = 0.04). At 6 months of observation 15 (56%) of 27 acyclovir-treated patients had returned to normal life compared with 3 (13%) of 24 vidarabine-treated patients (p = 0.002); and the numbers who died or had severe sequelae were 9 (33%) and 19 (76%), respectively (p = 0.005). No important or new adverse events were recognised." @default.
- W2149507482 created "2016-06-24" @default.
- W2149507482 creator A5015731703 @default.
- W2149507482 creator A5016310513 @default.
- W2149507482 creator A5021445133 @default.
- W2149507482 creator A5022027746 @default.
- W2149507482 creator A5025912323 @default.
- W2149507482 creator A5037858693 @default.
- W2149507482 creator A5055221957 @default.
- W2149507482 creator A5056341745 @default.
- W2149507482 creator A5071996246 @default.
- W2149507482 creator A5076786746 @default.
- W2149507482 creator A5080567562 @default.
- W2149507482 creator A5087257879 @default.
- W2149507482 creator A5089243042 @default.
- W2149507482 creator A5090604451 @default.
- W2149507482 creator A5091659011 @default.
- W2149507482 date "1984-09-01" @default.
- W2149507482 modified "2023-10-15" @default.
- W2149507482 title "ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS" @default.
- W2149507482 cites W1584836283 @default.
- W2149507482 cites W1897072529 @default.
- W2149507482 cites W2008715866 @default.
- W2149507482 cites W2032465024 @default.
- W2149507482 cites W2044428235 @default.
- W2149507482 cites W2044738352 @default.
- W2149507482 cites W2045360603 @default.
- W2149507482 cites W2069922766 @default.
- W2149507482 cites W2086675506 @default.
- W2149507482 cites W2089645281 @default.
- W2149507482 cites W2102634265 @default.
- W2149507482 cites W2127313546 @default.
- W2149507482 cites W2146456178 @default.
- W2149507482 cites W2147050163 @default.
- W2149507482 cites W2320630792 @default.
- W2149507482 cites W2333553600 @default.
- W2149507482 cites W2418451262 @default.
- W2149507482 cites W3024724881 @default.
- W2149507482 cites W4236254399 @default.
- W2149507482 cites W4249248895 @default.
- W2149507482 cites W4255175837 @default.
- W2149507482 cites W4379790460 @default.
- W2149507482 doi "https://doi.org/10.1016/s0140-6736(84)92623-0" @default.
- W2149507482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6148470" @default.
- W2149507482 hasPublicationYear "1984" @default.
- W2149507482 type Work @default.
- W2149507482 sameAs 2149507482 @default.
- W2149507482 citedByCount "515" @default.
- W2149507482 countsByYear W21495074822012 @default.
- W2149507482 countsByYear W21495074822013 @default.
- W2149507482 countsByYear W21495074822014 @default.
- W2149507482 countsByYear W21495074822015 @default.
- W2149507482 countsByYear W21495074822016 @default.
- W2149507482 countsByYear W21495074822017 @default.
- W2149507482 countsByYear W21495074822018 @default.
- W2149507482 countsByYear W21495074822019 @default.
- W2149507482 countsByYear W21495074822020 @default.
- W2149507482 countsByYear W21495074822021 @default.
- W2149507482 countsByYear W21495074822022 @default.
- W2149507482 countsByYear W21495074822023 @default.
- W2149507482 crossrefType "journal-article" @default.
- W2149507482 hasAuthorship W2149507482A5015731703 @default.
- W2149507482 hasAuthorship W2149507482A5016310513 @default.
- W2149507482 hasAuthorship W2149507482A5021445133 @default.
- W2149507482 hasAuthorship W2149507482A5022027746 @default.
- W2149507482 hasAuthorship W2149507482A5025912323 @default.
- W2149507482 hasAuthorship W2149507482A5037858693 @default.
- W2149507482 hasAuthorship W2149507482A5055221957 @default.
- W2149507482 hasAuthorship W2149507482A5056341745 @default.
- W2149507482 hasAuthorship W2149507482A5071996246 @default.
- W2149507482 hasAuthorship W2149507482A5076786746 @default.
- W2149507482 hasAuthorship W2149507482A5080567562 @default.
- W2149507482 hasAuthorship W2149507482A5087257879 @default.
- W2149507482 hasAuthorship W2149507482A5089243042 @default.
- W2149507482 hasAuthorship W2149507482A5090604451 @default.
- W2149507482 hasAuthorship W2149507482A5091659011 @default.
- W2149507482 hasConcept C126322002 @default.
- W2149507482 hasConcept C141071460 @default.
- W2149507482 hasConcept C159047783 @default.
- W2149507482 hasConcept C188816634 @default.
- W2149507482 hasConcept C197934379 @default.
- W2149507482 hasConcept C2522874641 @default.
- W2149507482 hasConcept C2776694085 @default.
- W2149507482 hasConcept C2776755627 @default.
- W2149507482 hasConcept C2778779478 @default.
- W2149507482 hasConcept C2779263901 @default.
- W2149507482 hasConcept C71924100 @default.
- W2149507482 hasConcept C83455156 @default.
- W2149507482 hasConcept C90924648 @default.
- W2149507482 hasConceptScore W2149507482C126322002 @default.
- W2149507482 hasConceptScore W2149507482C141071460 @default.
- W2149507482 hasConceptScore W2149507482C159047783 @default.
- W2149507482 hasConceptScore W2149507482C188816634 @default.
- W2149507482 hasConceptScore W2149507482C197934379 @default.
- W2149507482 hasConceptScore W2149507482C2522874641 @default.
- W2149507482 hasConceptScore W2149507482C2776694085 @default.
- W2149507482 hasConceptScore W2149507482C2776755627 @default.
- W2149507482 hasConceptScore W2149507482C2778779478 @default.